Jenny J. Zhang, Ph.D. - Publications

Affiliations: 
2002 Medical University of South Carolina, Charleston, SC, United States 
Area:
Biochemistry, Molecular Biology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery. Human Gene Therapy. 17: 545-55. PMID 16716111 DOI: 10.1089/Hum.2006.17.545  0.748
2004 Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney International. 66: 722-32. PMID 15253727 DOI: 10.1111/J.1523-1755.2004.00794.X  0.743
2003 Agata J, Zhang JJ, Chao J, Chao L. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regulatory Peptides. 112: 115-20. PMID 12667632 DOI: 10.1016/S0167-0115(03)00029-6  0.655
2001 Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, Chao L. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides. 22: 1731-7. PMID 11754958 DOI: 10.1016/S0196-9781(01)00510-1  0.786
2000 Zhang JJ, Yoshida H, Chao L, Chao J. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats. Human Gene Therapy. 11: 1817-27. PMID 10986555 DOI: 10.1161/01.Hyp.36.Suppl_1.691-A  0.775
2000 Yoshida H, Zhang JJ, Chao L, Chao J. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension. 35: 25-31. PMID 10642270 DOI: 10.1161/01.Hyp.35.1.25  0.649
1999 Zhang JJ, Wang C, Lin KF, Chao L, Chao J. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 21: 1145-60. PMID 10513833 DOI: 10.3109/10641969909052194  0.732
1999 Zhang JJ, Chao L, Chao J. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats. Stroke; a Journal of Cerebral Circulation. 30: 1925-31; discussion . PMID 10471446 DOI: 10.1161/01.Str.30.9.1925  0.702
1998 Chao J, Zhang JJ, Lin KF, Chao L. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats. Kidney International. 54: 1250-60. PMID 9767541 DOI: 10.1046/J.1523-1755.1998.00104.X  0.775
1998 Chao J, Zhang JJ, Lin KF, Chao L. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Human Gene Therapy. 9: 21-31. PMID 9458239 DOI: 10.1089/Hum.1998.9.1-21  0.787
1997 Jin L, Zhang JJ, Chao L, Chao J. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats. Human Gene Therapy. 8: 1753-61. PMID 9358025 DOI: 10.1089/Hum.1997.8.15-1753  0.716
Show low-probability matches.